Amneal Pharmaceuticals competitive analysis

Latest publications and patents of Amneal Pharmaceuticals New

Explore the latest publications and patents granted to Amneal Pharmaceuticals, showcasing their recent innovations and technological advancements.

Last updated on: Sep 23, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Amneal Pharmaceuticals

Jun 17, 2020Pharmaceutical Composition Comprising EliglustatIntended To Grant

Latest PTAB cases involving Amneal Pharmaceuticals

Discover the latest PTAB cases involving Amneal Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 29, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Amneal Pharmaceuticals

IPR2025-00731Apr 11, 2025AMNEAL PHARMACEUTICALSNIVAGEN PHARMACEUTICALSDiscretionary Denial
IPR2025-00779Apr 11, 2025AMNEAL PHARMACEUTICALSNIVAGEN PHARMACEUTICALSDiscretionary Denial
IPR2020-00193Nov 27, 2019AMNEAL PHARMACEUTICALSCUBIST PHARMACEUTICALSInstitution Denied
IPR2019-00207Nov 6, 2018AMNEAL PHARMACEUTICALSALMIRALLFinal Written Decision
IPR2018-00943Apr 20, 2018AMNEAL PHARMACEUTICALSALKERMES PHARMA IRELANDTerminated-Settled
IPR2016-01580Aug 11, 2016AMNEAL PHARMACEUTICALSHOSPIRAInstitution Denied
IPR2016-01578Aug 10, 2016AMNEAL PHARMACEUTICALSHOSPIRATerminated-Settled
IPR2016-01577Aug 10, 2016AMNEAL PHARMACEUTICALSHOSPIRATerminated-Settled
IPR2016-01579Aug 10, 2016AMNEAL PHARMACEUTICALSHOSPIRATerminated-Settled
IPR2016-01413Jul 15, 2016AMNEAL PHARMACEUTICALSPURDUE PHARMA LPFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Amneal Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
AMNEAL PHARMACEUTICALS - - 31 - Highly Aggressive
ENDO PHARMACEUTICALS - - - 4Non-Active
HOSPIRA - 387Balanced
JAZZ PHARMACEUTICALS - - - 23Non-Active